Putting her life and career as a health worker on hold was proof of Mary’s deep love for ... including the joints, skin, kidneys, blood cells, brain, heart, and lungs. “Lupus can be difficult ...

Has the recent Tuberculosis outbreak in Kansas got you worried about catching TB? Learn about the top symptoms to look out ...

The POC test will measure the TB biomarker LAM in urine, with Fluxus already having a prototype ultrasensitive LAM assay on its benchtop analyser platform. It will leverage Fluxus’ technology ...

A proof-of-concept study will test VAS-101, a topical gel using the turmeric extract curcumin, in sickle cell disease (SCD) ...

"TB remains a critical public health concern in low-income countries and diagnosis using a cheap, simple test like we've developed is needed not only to treat patients with TB but prevent further ...

The US Food and Drug Administration (FDA) has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test. This approval introduces an ...

The test will utilize Fluxus’ novel single-molecule counting technology, with the potential to be used for both pulmonary and extrapulmonary TB in all patient populations. According to the World ...

‘What if I told you #artificial_intelligence is now a super-sleuth in the fight against #tuberculosis, with accuracy levels that could revolutionize healthcare? Mind blown. #TB #AI #healthtech ...

“The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test gives laboratories the ability to process latent TB tests at higher volumes without compromising clinical accuracy,” said Yves ...

At present, they still have to rely on a crude "skin prick" test that has been in use for 100 years and often gives misleading results. TB causes more deaths worldwide than any other infectious ...

The NHS is accelerating its efforts to provide cutting-edge cancer treatments, with a new vaccine trial opening for patients with advanced skin cancer. This initiative is part of the NHS Cancer ...